Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

This Signal Points To More Upside In Stocks

NEW MONTHLY SIGNALS The MSCI World Index tracks over one thousand large and mid-cap stocks in twenty-two developed countries, covering 85% of the market capitalization in those regions. As shown via the chart below, a positive monthly MACD cross was just nailed down on the...
Chris Ciovacco | December 3, 2019 |

These Charts Say 2018 Was A Major Bottom

RECENT SIGNAL SEEN NEAR 2002 AND 2009 LOWS As shown in the chart below, the S&P 500 Bullish Percent Index (BPSPX) recently completed a bullish turn that has only taken place two previous times since 1996. In late December 2018, BPSPX reached a rare oversold state denoted b...
Chris Ciovacco | February 11, 2020 |

Psychedelic Leader to Advance Mental Health in 2021 with Growth of Clinics, Lab and Partnerships

(Image via Numinus Wellness Inc.) In 2020, Health Canada began allowing select patients to take psilocybin for relief of end-of-life-distress. This was followed by a proposed regulation revision that could allow doctors to prescribe both psilocybin and MDMA for t...
Stockhouse Editorial | January 14, 2021 |

Global Dow Nails Down Bullish Signal

SIGN OF GROWING CONFIDENCE At the end of November, monthly CCI completed a momentum round trip by closing above 100 after closing below -100 in late 2018. CCI helps us track market momentum. The turn that just took place over the last year is typically associated with a si...
Chris Ciovacco | December 18, 2019 |

The Six Most Powerful Charts On Wall Street

THIS IS WHAT A MAJOR TREND REVERSAL LOOKS LIKE The three periods shown below produced an average peak-to-trough loss of over 50%. Thus, it is prudent to understand some of the common characteristics found in all three cases. We can then look for similar characteristics in ...
Chris Ciovacco | October 16, 2019 |

Bulls Trying To Make A Stand

DOOR TO A BULLISH BOTTOMING PROCESS REMAINS OPEN During the trading session on Monday, August 19, the “bottoming process” case for the stock market remained intact. The NYSE Common Stock A-D Line held the line last week at a logical level associated w...
Chris Ciovacco | August 21, 2019 |

Mobile Health and Telemedicine Provider for Community-Based Healthcare Teams Up with ...

Mobile Health and Telemedicine Provider for Community-Based Healthcare Teams Up with US Health Data Firm Reliq Health Technologies advised that it has been selected as remote patient monitoring and chronic care management solutions partner by U.S. health data...
Streetwise Reports | February 27, 2020 |

Mesoblast Shares Soar 120% After Reporting 83% Survival Rate in COVID-19 Patients with ARDS

Shares of Mesoblast more than doubled and set a new 52-week high price after the company reported that it achieved a 83% survival rate in New York ventilator-dependent COVID-19 patients with moderate to severe acute respiratory distress syndrome who were treated with its all...
Streetwise Reports | April 27, 2020 |

Biotech's New Mesothelioma Trial Data Show Efficacy, Immunogenicity

These results of a study evaluating Targovax's lead candidate are reviewed and commented on in an H.C. Wainwright & Co. report. In a June 22 research note, H.C. Wainwright & Co. analyst Joseph Pantginis reported that Targovax ASA's (TRVX:OSE) ONCOS-102, in trial ...
Streetwise Reports | June 25, 2020 |

Silver options strategies that could be lucrative for investors

In last Wednesday's Money Morning special report on silver , several of our financial gurus projected higher prices ahead for "the other precious metal." Since then, silver has climbed about 5% -- hitting $43 an ounce yesterday (Monday). Silver is now nearing its record ...
Larry D. Spears | October 28, 2012 |
1 2 3 4 5 6 7 8 9 10 ...